Cardinal Health Inc   (CAH)
Other Ticker:  
Price: $96.3900 $0.34 0.354%
Day's High: $96.75 Week Perf: -2.1 %
Day's Low: $ 95.66 30 Day Perf: -7.15 %
Volume (M): 1,207 52 Wk High: $ 116.04
Volume (M$): $ 116,333 52 Wk Avg: $98.63
Open: $96.41 52 Wk Low: $80.90

 Market Capitalization (Millions $) 23,616
 Shares Outstanding (Millions) 245
 Employees 46,500
 Revenues (TTM) (Millions $) 220,572
 Net Income (TTM) (Millions $) 553
 Cash Flow (TTM) (Millions $) -272
 Capital Exp. (TTM) (Millions $) 535

Cardinal Health Inc
Cardinal Health, Inc., an Ohio corporation formed in 1979, is a holding company encompassing a number of operating subsidiaries that do business as Cardinal Health. The Company is a leading provider of products and services supporting the health care industry, and helping health care providers and manufacturers improve the efficiency and quality of health care.

The Company has four reporting segments. They are: Pharmaceutical Distribution and Provider Services, Medical Products and Services, Pharmaceutical Technologies and Services and Automation and Information


Through its Pharmaceutical Distribution and Provider Services segment, the Company distributes a broad line of pharmaceutical and other health care products and provides pharmacy management and related consulting services to hospital, retail and alternate-site pharmacies. The Companys Pharmaceutical Distribution business is one of the countrys leading wholesale distributors of pharmaceutical and related health care products to independent and chain drug stores, hospitals, alternate care centers and the pharmacy departments of supermarkets and mass merchandisers located throughout the United States.


Through its Medical Products and Services segment, the Company provides medical products and services and cost-saving services to hospitals and other health care providers. For example, the Company offers a broad range of medical and laboratory products, representing approximately 2,000 suppliers in addition to its own line of surgical and respiratory therapy products to hospitals and other health care providers.


Through its Pharmaceutical Technologies and Services segment, the Company provides a broad range of technologies and services to the pharmaceutical, life sciences and consumer health industry. This segments Oral Technologies business provides proprietary drug delivery technologies, including softgel capsules, controlled release forms and Zydis(R) fast dissolving wafers, and manufacturing for nearly all traditional oral dosage forms.


The Company, through its Automation and Information Services segment, operates businesses focusing on meeting customer needs through unique and proprietary automation and information products and services. For example, this segment develops, manufactures, leases, sells and services bedside clinical and patient entertainment systems as well as point-of-use systems that automate the distribution and management of medications and supplies in hospitals and other health care facilities.


The Companys largest retail distribution customer in its Pharmaceutical Distribution and Provider Services segment, CVS Meridian, Inc. ("CVS"). The Company could be adversely affected if the business of this customer were lost. The two largest retail bulk distribution customers in the Pharmaceutical Distribution and Provider Services segment are CVS and Walgreens Co.


The markets in which the Company operates generally are highly competitive.

In the Pharmaceutical Distribution and Provider Services segment, the Companys pharmaceutical wholesale distribution business competes directly with two other national wholesale distributors (McKesson Corporation and AmerisourceBergen Corporation) and smaller regional wholesale distributors, direct selling manufacturers, self-warehousing chains and specialty distributors on the basis of a value proposition that includes breadth of product lines, marketing programs, support services and pricing.

In the Pharmaceutical Technologies and Services segment, the Company competes on several fronts including competition with other companies providing outsourcing services to pharmaceutical manufacturers as well as those manufacturers who choose to handle these services in-house. Specifically, in this segment, the Company competes as follows: the Oral Technologies business competes with providers of both new drug delivery technologies and existing delivery technologies; the Biotechnology and Sterile Life Sciences business competes with other providers of sterile fill/finish manufacturing and lyophilization services; the Pharmaceutical Development business competes with providers of contract discovery, development and analytical laboratory services and manufacture and packaging of clinical supplies; the Packaging Services business competes with companies that provide packaging components and packaging services; and the Healthcare Marketing Services business competes with other providers of medical education, marketing/product launch services, contract sales and product logistics services.

   Company Address: 7000 Cardinal Place Dublin 43017 OH
   Company Phone Number: 757-5000   Stock Exchange / Ticker: NYSE CAH

Customers Net Income grew by CAH's Customers Net Profit Margin grew to

36.96 %

4.18 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
MCK   -0.58%    
BDX   -3.52%    
DHR   -1.62%    
JNJ   -2.84%    
KMB   -1.26%    
MMM   -5.27%    
• View Complete Report

Cardinal Health Inc

Cardinal Health Inc Reports Decrease in Income Per Share But Increase in Revenue for Fiscal Q3 2024

Cardinal Health Inc, a Pharmacy Services & Retail Drugstore company, has released its financial results for the most recent fiscal period, revealing a decrease in its income per share and an increase in revenue. The company reported earnings per share of $1.05 and revenue of $57.45 billion for the period ending March 31, 2023. This marks a decline from the previous fiscal period in which the company earned $1.34 per share.
Although the income per share fell, Cardinal Health Inc saw its revenue rise by 8.763% in the comparable period. However, in contrast to the previous quarter, the company experienced a decrease in revenue by -4.411% from $57.45 billion. Furthermore, income faded by -26.57% from $1.43 per share during the second quarter.

Cardinal Health Inc

Cardinal Health Inc Surges Ahead with Spectacular Q2 Revenue Surge: A Promising Outlook for the Pharmacy Services & Retail Drugstore Leader

Cardinal Health Inc, a leading healthcare services company, has shown strong growth in its shares and financial results. With a notable increase in earnings per share (EPS), revenue, and net earnings, the company seems poised for continued success. This article aims to analyze the impact of these positive developments on Cardinal Health Inc's future prospects.
1. Share Performance and Momentum:
Cardinal Health Inc shares have experienced a remarkable improvement of 8.36% in the past 30 days. Over the last 12 months, the shares have advanced by an impressive 75.72%. The shares are now only 1.9% away from reaching their 52-week high of $111.4. This upward trend indicates growing investor confidence and suggests a positive market reception for the company.

Cardinal Health Inc

Cardinal Health Inc's Earnings Soar by $32 Million Thanks to Tax Provisions

Cardinal Health Inc (CAH) experienced a challenging period in terms of earnings per share (EPS), with a significant decline of -95% to $0.02 per share in the first quarter of 2024. Despite this, the company saw impressive revenue growth of 10.403% to $54.76 billion compared to the same reporting period the previous year.
In the Pharmacy Services & Retail Drugstore sector, Cardinal Health Inc's revenue growth outpaced that of its contemporaries. Two-thirds of businesses in this industry experienced a top-line growth of 9.65% relative to the previous year.

Cardinal Health Inc

Cardinal Health Inc. Delivers Impressive Revenue Growth, but Investors Worry as Company Plunges into Deep Deficit

Cardinal Health Inc, a leading Pharmacy Services & Retail Drugstore company, recently released its financial results for the April to June 30, 2023 reporting season. While the company saw a significant increase in revenue, with a growth of 13.481% compared to the same period last year, it unfortunately slipped into a shortfall at $-0.27 per share.
In the previous reporting season, Cardinal Health Inc experienced a 5.875% increase in revenue from $50.49 billion, but its Income per Share fell from $1.34. This downward trend is concerning for investors and raises questions about the company's overall financial performance.

Cardinal Health Inc

Cardinal Health Inc. Makes a Remarkable Comeback, Achieving Profitability Amidst Economic Challenges and Pandemic

Cardinal Health Inc. has shown an impressive comeback in the third quarter of 2023, demonstrating its outstanding resilience, determination, and ability to thrive in a challenging economic climate amidst the ongoing COVID-19 pandemic. The company's success can be attributed to its effective strategy, financial discipline, and focus on innovation and sustainability.
For the third quarter of 2023, Cardinal Health Inc. announced a turnaround to surplus by displaying Income per Share of $1.34 per share, compared to $-5.05 a year ago. This represents a remarkable improvement of over 126% in EPS on a year-over-year basis. What's more, the net profit per share turned positive from $-0.50 per share from the preceding quarter. This achievement reflects the management's efficient cost-cutting measures, prudent allocation of resources, and the company's ability to adapt to new market trends and customer needs.


Cardinal Health Inc's Segments
 Segment     of total Revenue
 Segment     of total Revenue
 Segment     of total Revenue
• View Complete Report
  Company Estimates  
  Revenue Outlook
Cardinal Health Inc does not provide revenue guidance.

Earnings Outlook
Cardinal Health Inc issued annual earnings guidance on

Geographic Revenue Dispersion
United States


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com